SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson ...

The UAB Molecular Genetic Pathology Fellowship Program is participating in the Molecular Genetic Pathology Unified Timeline for the 2025-2026 fellowship year. For ...

BOSTON--(BUSINESS WIRE)--Invicro LLC, and Ambry Genetics, both Konica Minolta precision medicine companies and leading providers of quantitative biomarker and genomic profiling services, today ...

A 50-gene subtype predictor was developed using microarray and quantitative reverse transcriptase polymerase chain reaction data from 189 prototype samples. Test sets from 761 patients (no systemic ...

Baculoviruses are a diverse family of large, circular double‐stranded DNA viruses that infect insect larvae and play a pivotal role in natural microbial control. Advances in genomic technologies have ...

CEO Ming Hsieh highlighted year-over-year growth in the laboratory services segment and momentum in 2025. The company's therapeutic development pipeline progresses with FID-007 in Phase 2 trials for ...

The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new ...

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...

PURPOSETo improve on current standards for breast cancer prognosis and prediction of chemotherapy benefit by developing a risk model that incorporates the gene expression–based “intrinsic” subtypes ...